RE: Down Syndrome surpriseA biotech company with:
- modest revenue
- positive results for a prenatal downsyndrome drug test
- investment from big money managers
- an expected growth rate of 43% for the coming year
With all this, raising more cash seems to be a non-issue... I'm not seeing a downside to investing